inno.N said that it would collaborate with Novacell technology to develop a peptide-based autoimmune disease treatment.Under the accord, Novacell will discover candidate substances for anti-inflammatory peptides, and inno.N plans to conduct additional research and clinical trials on the substance wi
The Korean Medical Association (KMA) said the health authorities should restrict the general public's use of Covid-19 home test kits.The doctors' group said that reckless use of self-test kits partially contributed to the continuing spike in Covid-19 cases despite the strictest Level 4 social distan
The health authorities said they would recognize vaccine trial participants as fully vaccinated to encourage participation in local Covid-19 vaccine studies.Earlier on Aug. 19, the Ministry of Health and Welfare announced plans to support quick phase 3 trials of Covid-19 vaccines and issue vaccinati
Biopharmaceutical companies are the biggest beneficiaries of the Covid-19 outbreak, but financial reports of such companies showed that despite their hefty gains, they offered little in social contributions.Local drugmakers have significantly improved their performance due to the outbreak of Covid-1
Korea may change its quarantine policy to the "With Corona" system from late October, Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong said Tuesday.The "With Corona" plan refers to the shift of the quarantine system to focusing on severe patients while letting most ot
A joint research team has confirmed that the risk of end-stage renal disease requiring transplantation or dialysis increases in cancer patients.The team, led by Professors Kim Chang-sung and Kim Su-hwan at Chonnam National University Hospital and Han Kyung-do at Soongsil University, concluded so aft
The first and only targeted therapy to treat hormone receptor-positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) metastatic breast cancer with PIK3CA gene mutation arrived in Korea recently.However, it is uncertain whether it can get health insurance benefits.In May, Novart
Hanall Biopharma is one of the most frequently mentioned Korean drugmakers when analysts forecast the arrival of a global blockbuster drug. In developing autoimmune disease treatment candidate HL161(batoclimab), there are many ongoing clinical trials of batoclimab by partners in the U.S. and China t
The number of foreigners getting medical treatment in Korea decreased by more than half last year, a government report said.Thanks to Korean physicians’ excellent techniques, relatively lower hospital bills, and the government’s push to turn the medical industry into another hard-currency earner, th
Sanofi-Aventis Korea has confirmed the safety and efficacy profile of Dupixent (ingredient: dupilumab) in treating children with uncontrolled moderate-to-severe atopic dermatitis in recent studies.The company conducted phase 2/3 LIBERTY AD PRESCHOOL clinical trials with 162 patients aged six months
Locally developed drug pipelines have increased rapidly in the past three years, industry data showed.On Monday, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) released the case study results of new drug pipelines and license transfer conducted for domestic pharmaceutical
JW Pharmaceutical’s anti-gout drug URC102 received certification from the European Patent Office (EPO) as a source technology.The patent is the company’s method to prepare a compound that works as the main ingredient and intermediate of URC102. URC102, developed as a new oral drug, inhibits uric aci
President Moon Jae-in on Monday raised the possibility of a significant shift in Korea's quarantine system as the nation's vaccination program gains pace."With the active participation of the public, the vaccination rate is rapidly increasing," Moon said. "The number of primary vaccinations has exce
Novartis Korea has introduced its combination therapy of Piqray (ingredient: alpelisib) and fulvestrant, saying it could prolong the treatment period and overall survival (OS) of breast cancer patients with major genetic mutations.In May, the company’s breast cancer drug received approval from the M
Seegene said it launched Novaplex SARS-CoV-2 Variants V Assay, a new concept diagnostic reagent that detects the Delta and Lambda variants."We have been leading the world's prevention of Covid-19 by developing diagnostic reagents for each mutant virus since the early days of the outbreak," the compa
Recently in Korea, autopsies, which can provide conclusive evidence in criminal investigation, have been increasing. However, the number of medical examiners, also known as forensic pathologists, has been decreasing.According to the National Forensic Service (NFS), it takes more than 9,000 requests
The government decided to give reimbursement for CSL Behring’s hemophilia treatment, Abstilla, from June. SK Chemicals developed the original substance of the drug and transferred the technology to CSL Behring in 2009.The key developers of Abstilla separated from SK Chemicals and established TiumBio
Pharmanovia, a U.K.-based multinational pharmaceutical company, said that it has established a Korean branch and appointed Yim Yoon-ah as its first country manager."Founded in 2013 and headquartered in Basildon, U.K., Pharmanovia operates a portfolio of more than 20 brands with over 250 employees in
Boehringer Ingelheim's SGLT-2 inhibitor Jardiance (ingredient: empagliflozin) received attention at the 2021 European Society of Cardiology (ESC) by unveiling the results of phase 3 EMPEROR-Preserved trial in heart failure with preserved ejection fraction (HFpEF).Sodium-Glucose Co-Transporter 2 (SGL
A research team at St. Mary's Seoul Hospital has identified a method to measure micro-residual leukemia, a risk factor for recurrence of acute myeloid leukemia, and predict recurrence and survival rate.According to the hospital, acute myeloid leukemia, the most common acute leukemia, is characterize